Search results for "Coronary thrombolysis"

showing 2 items of 2 documents

Combined medical and mechanical recanalization in acute myocardial infarction

1985

A technique of combined medical and mechanical recanalization was employed in 96 patients with acute transmural myocardial infarction. The mean time between onset of symptoms and admission to hospital was 170 +/- 65 min (X +/- SD). After 10 +/- 16 min, 250,000 U streptokinase was administered intravenously for 20 min. Intracoronary thrombolysis was commenced within 38 +/- 14 min. First coronary angiograms demonstrated reperfusion, an open vessel in 25/96 patients (26%). In 15/71 patients (21%) reperfusion occurred during thrombolysis therapy, before mechanical recanalization could be performed. Recanalization was achieved mechanically in 37/71 patients (52%) with occluded coronary vessels. …

Malemedicine.medical_specialtymedicine.medical_treatmentStreptokinaseMyocardial InfarctionCoronary DiseaseAnterior myocardial infarctionElectrocardiographyRecurrenceCoronary CirculationInternal medicinemedicineHumansInfusions ParenteralStreptokinaseMyocardial infarctionAgedChemotherapybusiness.industryHemodynamicsArrhythmias CardiacStroke VolumeThrombolysisMiddle Agedmedicine.diseaseCombined Modality TherapyMyocardial ContractionPeripheralCoronary vesselCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAngioplasty Balloonmedicine.drugIntracoronary thrombolysisCatheterization and Cardiovascular Diagnosis
researchProduct

Coronary thrombolysis with tissue-type plasminogen activator (t-PA)

1985

Coronary thrombolysis is presently under intensive investigation as a treatment for acute myocardial infarction for two main reasons. Firstly it is now well established that acute myocardial infarction is often associated with thrombotic occlusion of an atherosclerotic coronary artery [1]. Secondly it has been shown that administration of thrombolytic agents can reopen an occluded coronary artery in the majority of patients [2, 3] and that reperfusion of ischemic myocardial tissue is generally well tolerated. Coronary thrombolysis is however not a goal in itself but is employed to prevent necrosis and dysfunction of jeopardized myocardial cells. There is ample evidence in animals that the i…

medicine.medical_specialtyNecrosisbusiness.industryCoronary reperfusionmedicine.diseasemedicine.anatomical_structureCoronary thrombosisInternal medicineCoronary thrombolysismedicineCardiologyThrombolytic AgentMyocardial infarctionmedicine.symptombusinessPlasminogen activatorArtery
researchProduct